Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2013

01.02.2013 | Retinal Disorders

Recovery of photoreceptor outer segments after anti-VEGF therapy for age-related macular degeneration

verfasst von: Akio Oishi, Masataka Shimozono, Michiko Mandai, Masayuki Hata, Akihiro Nishida, Yasuo Kurimoto

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate whether the status of the external limiting membrane (ELM) or inner segment/outer segment junction (IS/OS) improves after intravitreal injection of ranibizumab for age-related macular degeneration (AMD). We also evaluated whether the pre-operative values of these parameters are associated with the visual prognosis.

Methods

This was a hospital-based, cross-sectional study. Seventy-six eyes of 76 treatment-naive AMD patients who received three monthly intravitreal injections of ranibizumab followed for more than 6 months with additional as-needed injections were investigated. Spectral domain OCT was used to evaluate the length of ELM, IS/OS, and foveal thickness pre- and post-operatively. Changes of ELM and IS/OS length were evaluated postoperatively. Correlation coefficients between pre-operative parameters and post-operative visual acuity were also analyzed.

Results

Significant changes were noted in mean logMAR (0.66 to 0.53), foveal thickness (231.1 to 151.1 μm), and IS/OS length (514.9 to 832.3 μm) after the treatment. ELM length did not improve significantly (1,312.4 to 1,376.7 μm). Restoration of IS/OS occured where ELM is retained. Although pre-operative ELM length, IS/OS length, and foveal thickness showed correlation with post-operative logMAR (R = –0.51, –0.39, and 0.46, respectively), the most powerful predictive factor for visual prognosis was pre-operative logMAR (R = 0.77, p < 0.001).

Conclusions

IS/OS status improves in response to anti-VEGF therapy but ELM seems to have less plasticity. The status of IS/OS and ELM can be used as prognostic factors but the predictive power is inferior to that of baseline visual acuity.
Literatur
1.
Zurück zum Zitat Coker JG, Duker JS (1996) Macular disease and optical coherence tomography. Curr Opin Ophthalmol 7:33–38PubMedCrossRef Coker JG, Duker JS (1996) Macular disease and optical coherence tomography. Curr Opin Ophthalmol 7:33–38PubMedCrossRef
2.
Zurück zum Zitat Salinas-Alamán A, Garcia-Layana A, Maldonado MJ, Sainz-Gomez C, Alvarez-Vidal A (2005) Using optical coherence tomography to monitor photodynamic therapy in age-related macular degeneration. Am J Ophthalmol 140:23–28PubMedCrossRef Salinas-Alamán A, Garcia-Layana A, Maldonado MJ, Sainz-Gomez C, Alvarez-Vidal A (2005) Using optical coherence tomography to monitor photodynamic therapy in age-related macular degeneration. Am J Ophthalmol 140:23–28PubMedCrossRef
3.
Zurück zum Zitat Kashani AH, Keane PA, Dustin L, Walsh AC, Sadda SR (2009) Quantitative subanalysis of intraretinal cystoid spaces and outer nuclear layer using optical coherence tomography in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 50:3366–3373PubMedCrossRef Kashani AH, Keane PA, Dustin L, Walsh AC, Sadda SR (2009) Quantitative subanalysis of intraretinal cystoid spaces and outer nuclear layer using optical coherence tomography in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 50:3366–3373PubMedCrossRef
4.
Zurück zum Zitat Landa G, Bukelman A, Katz H, Pollack A (2009) Early OCT changes of neuroretinal foveal thickness after first versus repeated PDT in AMD. Int Ophthalmol 29:1–5PubMedCrossRef Landa G, Bukelman A, Katz H, Pollack A (2009) Early OCT changes of neuroretinal foveal thickness after first versus repeated PDT in AMD. Int Ophthalmol 29:1–5PubMedCrossRef
5.
Zurück zum Zitat Keane PA, Liakopoulos S, Jivrajka RV, Chang KT, Alasil T, Walsh AC, Sadda SR (2009) Evaluation of optical coherence tomography central retinal thickness parameters for use as anatomic outcomes in clinical trials for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 50:3378–3385PubMedCrossRef Keane PA, Liakopoulos S, Jivrajka RV, Chang KT, Alasil T, Walsh AC, Sadda SR (2009) Evaluation of optical coherence tomography central retinal thickness parameters for use as anatomic outcomes in clinical trials for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 50:3378–3385PubMedCrossRef
6.
Zurück zum Zitat Drexler W, Sattmann H, Hermann B, Ko TH, Stur M, Unterhuber A, Scholda C, Findl O, Wirtitsch M, Fujimoto JG, Fercher AF (2003) Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol 121:695–706PubMedCrossRef Drexler W, Sattmann H, Hermann B, Ko TH, Stur M, Unterhuber A, Scholda C, Findl O, Wirtitsch M, Fujimoto JG, Fercher AF (2003) Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol 121:695–706PubMedCrossRef
7.
Zurück zum Zitat Ko TH, Fujimoto JG, Schuman JS, Paunescu LA, Kowalevicz AM, Hartl I, Drexler W, Wollstein G, Ishikawa H, Duker JS (2005) Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology 112:1922PubMedCrossRef Ko TH, Fujimoto JG, Schuman JS, Paunescu LA, Kowalevicz AM, Hartl I, Drexler W, Wollstein G, Ishikawa H, Duker JS (2005) Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology 112:1922PubMedCrossRef
8.
Zurück zum Zitat Hayashi H, Yamashiro K, Tsujikawa A, Ota M, Otani A, Yoshimura N (2009) Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. Am J Ophthalmol 148:83–89PubMedCrossRef Hayashi H, Yamashiro K, Tsujikawa A, Ota M, Otani A, Yoshimura N (2009) Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. Am J Ophthalmol 148:83–89PubMedCrossRef
9.
Zurück zum Zitat Sayanagi K, Sharma S, Kaiser PK (2009) Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol 93:622–626PubMedCrossRef Sayanagi K, Sharma S, Kaiser PK (2009) Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration. Br J Ophthalmol 93:622–626PubMedCrossRef
10.
Zurück zum Zitat Landa G, Su E, Garcia PM, Seiple WH, Rosen RB (2011) Inner segment-outer segment junctional layer integrity and corresponding retinal sensitivity in dry and wet forms of age-related macular degeneration. Retina 31:364–370PubMedCrossRef Landa G, Su E, Garcia PM, Seiple WH, Rosen RB (2011) Inner segment-outer segment junctional layer integrity and corresponding retinal sensitivity in dry and wet forms of age-related macular degeneration. Retina 31:364–370PubMedCrossRef
11.
Zurück zum Zitat Oishi A, Hata M, Shimozono M, Mandai M, Nishida A, Kurimoto Y (2010) The significance of external limiting membrane status for visual acuity in age-related macular degeneration. Am J Ophthalmol 150:27–32PubMedCrossRef Oishi A, Hata M, Shimozono M, Mandai M, Nishida A, Kurimoto Y (2010) The significance of external limiting membrane status for visual acuity in age-related macular degeneration. Am J Ophthalmol 150:27–32PubMedCrossRef
12.
Zurück zum Zitat Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi C (2009) OCT interpretation. In: Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi C (eds) Optical coherence tomography in age-related macular degeneration. Springer, Berlin Heidelberg New York, pp 97–170CrossRef Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi C (2009) OCT interpretation. In: Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi C (eds) Optical coherence tomography in age-related macular degeneration. Springer, Berlin Heidelberg New York, pp 97–170CrossRef
13.
Zurück zum Zitat Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi C (2009) Clinical features and natural history of AMD. In: Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi C (eds) Optical coherence tomography in age-related macular degeneration. Springer, Berlin Heidelberg New York, pp 171–274CrossRef Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi C (2009) Clinical features and natural history of AMD. In: Coscas G, Coscas F, Vismara S, Zourdani A, Li Calzi C (eds) Optical coherence tomography in age-related macular degeneration. Springer, Berlin Heidelberg New York, pp 171–274CrossRef
14.
Zurück zum Zitat Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431PubMedCrossRef Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431PubMedCrossRef
15.
Zurück zum Zitat Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432–1444PubMedCrossRef Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432–1444PubMedCrossRef
16.
Zurück zum Zitat Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116:57–65PubMedCrossRef Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116:57–65PubMedCrossRef
17.
Zurück zum Zitat Oishi A, Mandai M, Nishida A, Hata M, Matsuki T, Kurimoto Y (2011) Remission and dropout rate of anti-VEGF therapy for age-related macular degeneration. Eur J Ophthalmol 21:777–782PubMedCrossRef Oishi A, Mandai M, Nishida A, Hata M, Matsuki T, Kurimoto Y (2011) Remission and dropout rate of anti-VEGF therapy for age-related macular degeneration. Eur J Ophthalmol 21:777–782PubMedCrossRef
18.
Zurück zum Zitat Bressler NM (2009) Antiangiogenic approaches to age-related macular degeneration today. Ophthalmology 116:S15–S23PubMedCrossRef Bressler NM (2009) Antiangiogenic approaches to age-related macular degeneration today. Ophthalmology 116:S15–S23PubMedCrossRef
19.
Zurück zum Zitat Golbaz I, Ahlers C, Stock G, Schutze C, Schriefl S, Schlanitz F, Simader C, Prunte C, Schmidt-Erfurth UM (2011) Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy. Invest Ophthalmol Vis Sci 52:1599–1605PubMedCrossRef Golbaz I, Ahlers C, Stock G, Schutze C, Schriefl S, Schlanitz F, Simader C, Prunte C, Schmidt-Erfurth UM (2011) Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy. Invest Ophthalmol Vis Sci 52:1599–1605PubMedCrossRef
20.
Zurück zum Zitat Brown DM, Regillo CD (2007) Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol 144:627–637PubMedCrossRef Brown DM, Regillo CD (2007) Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol 144:627–637PubMedCrossRef
22.
Zurück zum Zitat Shimozono M, Oishi A, Hata M, Kurimoto Y (2011) Restoration of the photoreceptor outer segment and visual outcomes after macular hole closure: spectral-domain optical coherence tomography analysis. Graefes Arch Clin Exp Ophthalmol 249:1469–1476PubMedCrossRef Shimozono M, Oishi A, Hata M, Kurimoto Y (2011) Restoration of the photoreceptor outer segment and visual outcomes after macular hole closure: spectral-domain optical coherence tomography analysis. Graefes Arch Clin Exp Ophthalmol 249:1469–1476PubMedCrossRef
23.
Zurück zum Zitat Chiang A, Chang LK, Yu F, Sarraf D (2008) Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis. Retina 28:1265–1269PubMedCrossRef Chiang A, Chang LK, Yu F, Sarraf D (2008) Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis. Retina 28:1265–1269PubMedCrossRef
24.
Zurück zum Zitat Moroz I, Moisseiev J, Alhalel A (2009) Optical coherence tomography predictors of retinal pigment epithelial tear following intravitreal bevacizumab injection. Ophthalmic Surg Lasers Imaging 40:570–575PubMedCrossRef Moroz I, Moisseiev J, Alhalel A (2009) Optical coherence tomography predictors of retinal pigment epithelial tear following intravitreal bevacizumab injection. Ophthalmic Surg Lasers Imaging 40:570–575PubMedCrossRef
25.
Zurück zum Zitat Singh RP, Fu EX, Smith SD, Williams DR, Kaiser PK (2009) Predictive factors of visual and anatomical outcome after intravitreal bevacizumab treatment of neovascular age-related macular degeneration: an optical coherence tomography study. Br J Ophthalmol 93:1353–1358PubMedCrossRef Singh RP, Fu EX, Smith SD, Williams DR, Kaiser PK (2009) Predictive factors of visual and anatomical outcome after intravitreal bevacizumab treatment of neovascular age-related macular degeneration: an optical coherence tomography study. Br J Ophthalmol 93:1353–1358PubMedCrossRef
26.
Zurück zum Zitat Byun YJ, Lee SJ, Koh HJ (2010) Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Jpn J Ophthalmol 54:571–577PubMedCrossRef Byun YJ, Lee SJ, Koh HJ (2010) Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Jpn J Ophthalmol 54:571–577PubMedCrossRef
27.
Zurück zum Zitat Unver YB, Yavuz GA, Bekiroglu N, Presti P, Li W, Sinclair SH (2009) Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration. Eye (Lond) 23:453–460CrossRef Unver YB, Yavuz GA, Bekiroglu N, Presti P, Li W, Sinclair SH (2009) Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration. Eye (Lond) 23:453–460CrossRef
28.
Zurück zum Zitat Keane PA, Liakopoulos S, Chang KT, Wang M, Dustin L, Walsh AC, Sadda SR (2008) Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology 115:2206–2214PubMedCrossRef Keane PA, Liakopoulos S, Chang KT, Wang M, Dustin L, Walsh AC, Sadda SR (2008) Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology 115:2206–2214PubMedCrossRef
29.
Zurück zum Zitat Shimozono M, Oishi A, Hata M, Matsuki T, Ito S, Ishida K, Kurimoto Y (2012) The significance of cone outer segment tips as a prognostic factor in epiretinal membrane surgery. Am J Ophthalmol. doi:10.1016/j.ajo.2011.09.011 Shimozono M, Oishi A, Hata M, Matsuki T, Ito S, Ishida K, Kurimoto Y (2012) The significance of cone outer segment tips as a prognostic factor in epiretinal membrane surgery. Am J Ophthalmol. doi:10.​1016/​j.​ajo.​2011.​09.​011
Metadaten
Titel
Recovery of photoreceptor outer segments after anti-VEGF therapy for age-related macular degeneration
verfasst von
Akio Oishi
Masataka Shimozono
Michiko Mandai
Masayuki Hata
Akihiro Nishida
Yasuo Kurimoto
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 2/2013
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-012-2034-4

Weitere Artikel der Ausgabe 2/2013

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2013 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.